Re-Examining Genetic Screening and Oral Contraceptives: A Patient-Centered Review

The World Health Organization classifies combined hormonal contraception as an unacceptable health risk in the presence of a known thrombogenic mutation but advises against routine thrombophilia screening before initiating combined oral contraceptives (COCs) on the grounds of high screening costs an...

Descripción completa

Detalles Bibliográficos
Autores principales: Hiedemann, Bridget, Vernon, Erin, Bowie, Bonnie H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6462992/
https://www.ncbi.nlm.nih.gov/pubmed/30650548
http://dx.doi.org/10.3390/jpm9010004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6462992/
https://www.ncbi.nlm.nih.gov/pubmed/30650548
http://dx.doi.org/10.3390/jpm9010004

Ejemplares similares